This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.

The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.

Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.

By accessing this website you accept this legal notice and expressly confirm your status as a healthcare professional.

Peter
Adolfsson
Halland Kungsbacka Hospital and Halmstad Hospital, Halland and Halmstad, Sweden

Peter Adolfsson, MD, PhD, is a Senior Physician at the hospitals of Halland, Kungsbacka and Halmstad in Sweden. He received his medical training at the Sahlgrenska Academy of the Gothenburg University and, subsequently, went on to specialize in paediatrics, sports medicine and endocrinology.

 

Peter’s scientific interests focus on the impact of technology and exercise, including physical activities such as scuba diving, on diabetes in general. He is the first author of the 2018 ISPAD Clinical Practice Consensus Guidelines for exercise in children and adolescents with diabetes.

 

Peter is one of the original founders of diasend® and participated as a board member until the merge with glooko® in 2016. For this, Peter was awarded the ISPAD Prize for Innovation in 2017. 

 

During the last 3 years, Peter has focusedon implementing digital health in diabetes care, which has been evaluated in a randomized controlled trial. Now, he focusses on leading courses in diabetes technology and has created educational guides regarding the use of real-time and intermittently scanned continuous glucose monitoring. He has always believed that the appropriate use of technology can achieve the best results for his patients.